National Centre for
Pharmacoeconomics
NCPE Ireland
About Us
Current Staff
News
Glossary
Contact Us
Vacancies
Home
Submission Process
HTA Guidelines
Process Flowchart
Submission Templates
Pharmacoeconomic Evaluations
Drugs
Vaccines
Diagnostics and Other Technologies
Publications
Peer Reviewed Papers
Abstracts
Reports
Research
Pharmacoeconomic Research
Education
COVID-19
For Patients
Drugs
:
G
A
B
C
D
E
F
G
H
I
L
M
N
O
P
R
S
T
U
V
Z
Galcanezumab (Emgality®). HTA ID 20052
Gefitinib (Iressa®)
Gemtuzumab ozogamicin (Mylotarg®)
Gilteritinib (Xospata®) for Relapsed or Refractory AML. HTA ID: 19043
Glasdegib (Daurismo®) in combination with low-dose cytarabine. HTA ID: 20041
Glecaprevir/Pibrentasvir (Maviret®)
Glucosamine sulfate (Dona®)
Glycerol Phenylbutyrate (Ravicti®)
Glycopyrronium bromide (Seebri Breezhaler®)
Glycopyrronium bromide (Sialanar®)
1
2
Next Page
health check